Docetaxel in Treating Women With Ovarian Epithelial or Primary Peritoneal Cancer
Completed · Phase 2
Conditions studied: Ovarian Cancer, Peritoneal Cavity Cancer
In brief
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. PURPOSE: Phase II trial to study the effectiveness of docetaxel in treating women who have ovarian epithelial cancer or primary peritoneal cancer that has not responded to previous treatment.
Key facts
- Study ID
- NCT00004081
- Run by
- Beth Israel Deaconess Medical Center
- People needed
- 30
- Starts
- 1999-07-01
- Expected to finish
- 2003-03-01
- Last updated by the study team
- 2012-08-13
Who can join
Age: 18 and older. Sex: female. Healthy volunteers: not accepted.
Where it is running
- Beth Israel Deaconess Medical Center — Boston, Massachusetts, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.